UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could taking a break from CLL drug improve outcomes for frail patients?
Disease control OngoingThis study looks at whether older, frail patients with untreated chronic lymphocytic leukemia (CLL) can safely stop taking the targeted drug acalabrutinib after 18 months and then restart it only if their disease comes back. The goal is to reduce long-term side effects and lower …
Matched conditions: UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated May 17, 2026 09:22 UTC
-
New pill shows promise in slowing untreated leukemia
Disease control OngoingThis study tests whether a targeted drug called acalabrutinib works better than a standard combination of chemotherapy (chlorambucil) and an antibody (rituximab) for people with untreated chronic lymphocytic leukemia (CLL). About 155 adults aged 65 or older (or younger with certa…
Matched conditions: UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:53 UTC